Mcam silencing with RNA interference using magnetofection has antitumor effect in murine melanoma

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e205-

  Prosen, Lara ^a   Markelc, Bostjan ^b   Dolinsek, Tanja ^b   Music, Branka ^a   Cemazar, Maja ^b,c   Sersa, Gregor ^b  

^a KOLEKTOR GROUP D O O   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c UNIVERSITY OF PRIMORSKA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; PLASMID DNA; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPORATION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RNA INTERFERENCE;

EID: 84925246685     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.56     Document Type: Article

References (52)

1. Becker, GJ (2005). Recent developments in cancer therapy and why we need a human cancer genome project. J Am Coll Radiol 2: 887-888.
2. Ibraheem, D, Elaissari, A and Fessi, H (2014). Gene therapy and DNA delivery systems. Int J Pharm 459: 70-83.
3. Yarmush, ML, Golberg, A, Serša, G, Kotnik, T and Miklavčič, D (2014). Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 16: 295-320.
4. Heller, L, Todorovic, V and Cemazar, M (2013). Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas. Cancer Gene Ther 20: 695-700.
5. Dolinsek, T, Markelc, B, Sersa, G, Coer, A, Stimac, M, Lavrencak, J et al. (2013). Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth. PLoS One 8: e58723.
6. Gothelf, A and Gehl, J (2010). Gene electrotransfer to skin; review of existing literature and clinical perspectives. Curr Gene Ther 10: 287-299.
7. Tevz, G, Kranjc, S, Cemazar, M, Kamensek, U, Coer, A, Krzan, M et al. (2009). Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. J Gene Med 11: 1125-1137.
8. Markelc, B, Tevz, G, Cemazar, M, Kranjc, S, Lavrencak, J, Zegura, B et al. (2012). Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther 19: 312-320.
9. Rosazza, C, Phez, E, Escoffre, JM, Cézanne, L, Zumbusch, A and Rols, MP (2012). Cholesterol implications in plasmid DNA electrotransfer: Evidence for the involvement of endocytotic pathways. Int J Pharm 423: 134-143.
10. Plank, C, Scherer, F, Schillinger, U, Bergemann, C and Anton, M (2003). Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res 13: 29-32.
11. Prijic, S, Prosen, L, Cemazar, M, Scancar, J, Romih, R, Lavrencak, J et al. (2012). Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma. Biomaterials 33: 4379-4391.
12. Prosen, L, Prijic, S, Music, B, Lavrencak, J, Cemazar, M and Sersa, G (2013). Magnetofection: a reproducible method for gene delivery to melanoma cells. Biomed Res Int 2013: 209452.
13. Plank, C, Zelphati, O and Mykhaylyk, O (2011). Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects. Adv Drug Deliv Rev 63: 1300-1331.
14. Mykhaylyk, O, Zelphati, O, Hammerschmid, E, Anton, M, Rosenecker, J and Plank, C (2009). Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol 487: 111-146.
15. Buerli, T, Pellegrino, C, Baer, K, Lardi-Studler, B, Chudotvorova, I, Fritschy, JM et al. (2007). Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat Protoc 2: 3090-3101.
16. Krötz, F, de Wit, C, Sohn, HY, Zahler, S, Gloe, T, Pohl, U et al. (2003). Magnetofection-a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 7(5 Pt 1): 700-710.
17. Wang, Z and Yan, X (2013). CD146, a multi-functional molecule beyond adhesion. Cancer Lett 330: 150-162.
18. Yan, X, Lin, Y, Yang, D, Shen, Y, Yuan, M, Zhang, Z et al. (2003). A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102: 184-191.
19. Mills, L, Tellez, C, Huang, S, Baker, C, McCarty, M, Green, L et al. (2002). Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res 62: 5106-5114.
20. McGary, EC, Heimberger, A, Mills, L, Weber, K, Thomas, GW, Shtivelband, M et al. (2003). A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 9: 6560-6566.
21. Leslie, MC, Zhao, YJ, Lachman, LB, Hwu, P, Wu, GJ and Bar-Eli, M (2007). Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther 14: 316-323.
22. Kang, Y, Wang, F, Feng, J, Yang, D, Yang, X and Yan, X (2006). Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res 16: 313-318.
23. Todorovic, V, Sersa, G and Cemazar, M (2013). Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28. Cancer Gene Ther 20: 208-210.
24. Wu, Z, Wu, Z, Li, J, Yang, X, Wang, Y, Yu, Y et al. (2012). MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells. Tumour Biol 33: 1619-1628.
25. Zabouo, G, Imbert, AM, Jacquemier, J, Finetti, P, Moreau, T, Esterni, B et al. (2009). CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res 11: R1.
26. Chen, W, Zhang, HL, Jiang, YG, Li, JH, Liu, BL and Sun, MY (2009). Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell. J Oral Pathol Med 38: 198-205.
27. Wang, P, Luo, Y, Duan, H, Xing, S, Zhang, J, Lu, D et al. (2013). MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol 33: 3689-3699.
28. Huang, C, Li, M, Chen, C and Yao, Q (2008). Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets 12: 637-645.
29. Li, F and Mahato, RI (2011). RNA interference for improving the outcome of islet transplantation. Adv Drug Deliv Rev 63: 47-68.
30. Golzio, M, Mazzolini, L, Ledoux, A, Paganin, A, Izard, M, Hellaudais, L et al. (2007). In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther 14: 752-759.
31. Prijic, S and Sersa, G (2011). Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol 45: 1-16.
32. Heller, LC and Heller, R (2010). Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 10: 312-317.
33. Tesic, N and Cemazar, M (2013). In vitro targeted gene electrotransfer to endothelial cells with plasmid DNA containing human endothelin-1 promoter. J Membr Biol 246: 783-791.
34. Namgung, R, Singha, K, Yu, MK, Jon, S, Kim, YS, Ahn, Y et al. (2010). Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. Biomaterials 31: 4204-4213.
35. Krötz, F, Sohn, HY, Gloe, T, Plank, C and Pohl, U (2003). Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 40: 425-434.
36. Prijic, S, Scancar, J, Romih, R, Cemazar, M, Bregar, VB, Znidarsic, A et al. (2010). Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field. J Membr Biol 236: 167-179.
37. Huth, S, Lausier, J, Gersting, SW, Rudolph, C, Plank, C, Welsch, U et al. (2004). Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 6: 923-936.
38. Wang, Z, Tiruppathi, C, Cho, J, Minshall, RD and Malik, AB (2011). Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life 63: 659-667.
39. Mathew, R and White, E (2011). Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. Cold Spring Harb Symp Quant Biol 76: 389-396.
40. Ma, YJ and Gu, HC (2007). Study on the endocytosis and the internalization mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro. J Mater Sci Mater Med 18: 2145-2149.
41. Golzio, M, Rols, MP and Teissié, J (2004). In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 33: 126-135.
42. Pavlin, M, Pucihar, G and Kandušer, M (2012). The role of electrically stimulated endocytosis in gene electrotransfer. Bioelectrochemistry 83: 38-45.
43. Rosazza, C, Buntz, A, Rieß, T, Wöll, D, Zumbusch, A and Rols, MP (2013). Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther 21: 2217-2226.
44. Satyamoorthy, K, Muyrers, J, Meier, F, Patel, D and Herlyn, M (2001). Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 20: 4676-4684.
45. Bu, P, Gao, L, Zhuang, J, Feng, J, Yang, D and Yan, X (2006). Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation. Mol Cancer Ther 5: 2872-2878.
46. Jahnke, A, Hirschberger, J, Fischer, C, Brill, T, Köstlin, R, Plank, C et al. (2007). Intratumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. J Vet Med A Physiol Pathol Clin Med 54: 599-606.
47. Hüttinger, C, Hirschberger, J, Jahnke, A, Köstlin, R, Brill, T, Plank, C et al. (2008). Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med 10: 655-667.
48. Kong, M, Li, X, Wang, C, Ding, C, Dong, A, Duan, Q et al. (2012). Tissue distribution and cancer growth inhibition of magnetic lipoplex-delivered type 1 insulin-like growth factor receptor shRNA in nude mice. Acta Biochim Biophys Sin (Shanghai) 44: 591-596.
49. Miao, L, Zhang, K, Qiao, C, Jin, X, Zheng, C, Yang, B et al. (2013). Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression. Nanomedicine 9: 141-150.
50. Cemazar, M, Golzio, M, Sersa, G, Hojman, P, Kranjc, S, Mesojednik, S et al. (2009). Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Ther 16: 635-644.
51. Schindelin, J, Arganda-Carreras, I, Frise, E, Kaynig, V, Longair, M, Pietzsch, T et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676-682.
52. Niemistö, A, Dunmire, V, Yli-Harja, O, Zhang, W and Shmulevich, I (2005). Robust quantification of in vitro angiogenesis through image analysis. IEEE Trans Med Imaging 24: 549-553.